Regarding the Kaplan–Meier survival curves, no significant differences were observed in OS between the HER2-low and HER2-IHC 0 groups for both HR-positive breast cancer and TNBC (P = 0.086 and 0.170, respectively) (Fig. 2a, c). This evidence concerns the gene ERBB2 and breast cancer.